Related by context. Frequent words. (Click for all words.) 71 chronic myeloid leukemia CML 71 imatinib mesylate 71 chronic lymphocytic leukemia CLL 70 dasatinib 70 metastatic renal cell carcinoma 70 nilotinib 70 chronic myelogenous leukemia CML 69 Ph + ALL 69 relapsed refractory 68 T#I mutation 67 EGFR inhibitors 67 vinorelbine 67 relapsed refractory multiple myeloma 67 myeloid 67 imatinib 67 decitabine 66 tyrosine kinase inhibitors 66 androgen independent 66 xenograft models 66 cutaneous T cell 66 FOLFIRI 65 Bortezomib 65 azacitidine 65 humanized anti 65 HER2 positive metastatic breast 65 castration resistant prostate cancer 64 interferon alfa 64 fludarabine 64 TELCYTA 64 BCR ABL 64 gastrointestinal stromal tumors 64 Lenalidomide 64 DMARD 64 biologic therapy 64 B CLL 64 HGS ETR1 64 dacarbazine 64 Imatinib 64 refractory multiple myeloma 64 N methyl 64 bortezomib 64 etoposide 64 Trastuzumab 63 disease modifying antirheumatic 63 lymphoma CTCL 63 systemic lupus erythematosus SLE 63 potent antiviral 63 vandetanib 63 glioblastoma multiforme GBM 63 tumor lysis syndrome 63 Rituximab 63 systemic lupus erythematosus 63 infliximab 63 tanespimycin 63 relapsed multiple myeloma 63 ifosfamide 63 itraconazole 63 myelodysplastic syndrome MDS 63 immunomodulator 63 nucleoside 63 Acute Myeloid Leukemia AML 63 DLBCL 63 lupus nephritis 63 tocilizumab 63 CA4P 63 unresectable 62 romidepsin 62 hepatocellular carcinoma HCC 62 hypercalcemia 62 temozolomide 62 refractory Hodgkin lymphoma 62 DMARDs 62 Erlotinib 62 Taxotere ® 62 nab paclitaxel 62 Solid Tumors 62 sunitinib 62 neoplastic 62 ceftriaxone 62 veltuzumab 62 plus gemcitabine 62 temsirolimus 62 EGFR mutations 62 selective inhibitor 62 Relapsed 62 rituximab 62 cell malignancies 62 immunomodulatory 62 BMS # 62 double blinded placebo 62 pharmacokinetic properties 61 orally bioavailable 61 Combination therapy 61 Pioglitazone 61 sorafenib 61 Doxorubicin 61 gefitinib 61 administered subcutaneously 61 gemcitabine 61 drugs DMARDs 61 chemotherapeutic agent